Valuation: Ha Tay Pharmaceutical

Market Cap 5,072B 195M 173M 162M 148M 278M 18.76B 281M 1.96B 759M 9.59B 733M 717M 30.79B P/E 2024
109x
P/E 2025 109x
Enterprise Value 5,171B 199M 177M 165M 150M 284M 19.13B 286M 2B 774M 9.78B 747M 731M 31.39B EV / Sales 2024
3.89x
EV / Sales 2025 2.68x
Free-Float
25%
Yield 2024 *
-
Yield 2025 -
1 day+3.13%
1 week+2.75%
Current month+8.74%
1 month-1.06%
3 months-13.18%
6 months-18.60%
Current year-20.00%
1 week 51,500
Extreme 51500
56,000
1 month 51,500
Extreme 51500
58,000
Current year 51,500
Extreme 51500
75,800
1 year 51,500
Extreme 51500
86,800
3 years 17,090.91
Extreme 17090.90909
100,818.18
5 years 11,980.52
Extreme 11980.519478
100,818.18
10 years 4,801.26
Extreme 4801.259345
100,818.18
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2016
Corporate Officer/Principal - 01/03/2016
Corporate Officer/Principal 49 04/02/2015
Director TitleAgeSince
Chairman 75 01/01/2016
Director/Board Member 53 -
Director/Board Member 62 01/06/2013
Change 5-day change 1-year change 3-year change Capi.($)
+3.13%+2.75%-26.67%+193.33% 195M
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average +0.10%-2.68%+21.79%+70.77% 369.74B
Weighted average by Cap. +0.42%-3.32%+30.51%+68.96%

Financials

2024 2025
Net sales 2,086B 80.29M 71.34M 66.58M 60.69M 114M 7.72B 116M 806M 312M 3.95B 301M 295M 12.66B 2,402B 92.44M 82.13M 76.66M 69.87M 132M 8.89B 133M 928M 359M 4.54B 347M 340M 14.58B
Net income 71.77B 2.76M 2.45M 2.29M 2.09M 3.94M 266M 3.97M 27.72M 10.74M 136M 10.37M 10.15M 436M 53.66B 2.06M 1.83M 1.71M 1.56M 2.94M 199M 2.97M 20.72M 8.03M 101M 7.75M 7.58M 326M
Net Debt 290B 11.16M 9.91M 9.25M 8.43M 15.9M 1.07B 16.05M 112M 43.39M 548M 41.89M 40.98M 1.76B 98.73B 3.8M 3.38M 3.15M 2.87M 5.42M 365M 5.47M 38.13M 14.78M 187M 14.26M 13.96M 599M
Logo Ha Tay Pharmaceutical
Hatay Pharmaceutical Joint Stock Company (Hataphar) is a Vietnam-based pharmaceutical company. It is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The Company also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The Company announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.
Employees
586
Date Price Change Volume
02/10/26 VND 56,000.00 +3.13% 29,833
01/10/26 VND 54,300.00 +5.44% 205
30/09/26 VND 51,500.00 -5.16% 3,400
29/09/26 VND 54,300.00 +0.56% 2,401
28/09/26 VND 54,000.00 -0.92% 6,501